Skip to main navigation Skip to search Skip to main content

Partially modified retro-inverso-enkephalinamides: Topochemical long-acting analogs in vitro and in vivo

  • Michael Chorev*
  • , Rick Shavitz
  • , Murray Goodman
  • , Scott Minick
  • , Roger Guillemin
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Abstract

The synthesis of four enkephalinamide analogs is described in which the peptide bond between residues 4 and 5 is reversed with or without simultaneous reversal of the carboxyl-terminal amide bond. These so-called partially modified retro-inverso-isomers are new, potent, topochemical analogs of the enkephalins. Tests, both in vitro and in vivo, have shown that these analogs are considerably longer acting than any previously studied enkephalins. Thus, partial reversal of the peptide bonds of the backbone can result in peptides with enhanced activity compared to a parent compound, provided that the structural complementarity of both the side chains and end groups are conserved.

Original languageEnglish
Pages (from-to)1210-1212
Number of pages3
JournalScience
Volume204
Issue number4398
DOIs
StatePublished - 1979
Externally publishedYes

Fingerprint

Dive into the research topics of 'Partially modified retro-inverso-enkephalinamides: Topochemical long-acting analogs in vitro and in vivo'. Together they form a unique fingerprint.

Cite this